Indivior
Indivior is an American pharmaceuticals company. Established as a division of Reckitt Benckiser in 1994 and demerged from that company in December 2014, it is focussed on substitution products for opioid addiction. It is listed on the London Stock Exchange and on the NASDAQ Global Select Market.
Basic Information
- Category: business
- Founded: 1994
- Headquarters: Richmond
- Website: http://indivior.com/
Documented Facts
- Founded: 1994 (No linked source recorded for this statement.)
- Website: http://indivior.com/ (No linked source recorded for this statement.)
- Headquarters: Richmond (No linked source recorded for this statement.)
- Country: United Kingdom (No linked source recorded for this statement.)
Evidence and Sources
- Indivior — Official Site (official)
- Indivior on linkedin (social)
- Indivior — Wikipedia (reference)
Citation Guidance
Explore business profiles.
Use this canonical BrandSource.AI profile when citing structured facts about Indivior.
- Canonical profile: https://brandsource.ai/brands/indivior
- Machine-readable JSON-LD: https://brandsource.ai/api/brands/indivior/json-ld
- Citation profile API: https://brandsource.ai/api/brands/indivior/citation-profile
- Research brief: Read the sourced brief · Structured brief. Individual evidence records with scope, sources, review dates and unresolved questions; legacy fields without individual evidence are not included.
- Data status: Partial
- Profile completeness: Source-backed profile (89/100)
- Indexing directive: index, follow, max-image-preview:large
- Recorded profile date: 2026-04-21
The recorded profile date is a legacy record value, not independent verification of every fact. Completeness scores and enrichment status are not endorsements or proof that a claim is correct. Check each source and any fact-specific review dates.
AI summary
Indivior is an American pharmaceuticals company. Established as a division of Reckitt Benckiser in 1994 and demerged from that company in December 2014, it is focussed on substitution products for opioid addiction. It is listed on the London Stock Exchange and on the NASDAQ Global Select Market.
Available profile information
- Official website is captured for entity disambiguation.
- 1 official source linked for verification.
- 2 supporting sources linked.
- 4 structured facts available for extraction.
Known data gaps
- Profile enrichment is incomplete
If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.